What are the treatment options for binge‑eating disorder in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment Options for Binge-Eating Disorder

Start with eating disorder-focused cognitive-behavioral therapy (CBT) or interpersonal therapy (IPT) as first-line treatment for binge-eating disorder, delivered in either individual or group formats 1.

Primary Treatment Approach: Psychotherapy First

The 2023 American Psychiatric Association guidelines provide clear direction: psychotherapy is the recommended first-line treatment for binge-eating disorder. The evidence strongly supports two specific modalities:

  • Cognitive-behavioral therapy (CBT) - eating disorder-focused
  • Interpersonal therapy (IPT)

Both can be delivered individually or in group settings, giving flexibility based on patient preference and resource availability 1. The research literature consistently demonstrates that CBT shows the largest effect sizes among psychological treatments, with durable benefits extending beyond the end of treatment 2, 3.

When to Add Medication

If the patient prefers medication initially or shows minimal/no response to psychotherapy alone, add either an antidepressant or lisdexamfetamine 1.

The guideline rates this as a suggestion (2C) rather than a firm recommendation, reflecting greater uncertainty in the benefit-harm balance. However, the medication options are:

Lisdexamfetamine (LDX)

  • Only FDA-approved medication for moderate-to-severe binge-eating disorder 2
  • Reduces binge-eating frequency (relative risk 2.61 for abstinence)
  • Reduces binge-eating-related obsessions/compulsions (mean difference -6.50)
  • Produces weight loss and appetite reduction 3
  • Common side effects: headache, gastrointestinal upset, sleep disturbance, sympathetic nervous system arousal (1.63-4.28 times more frequent than placebo) 3

Antidepressants (Second-Generation)

  • Increase binge-eating abstinence (relative risk 1.67)
  • Reduce binge-eating frequency and related psychopathology
  • Reduce depressive symptoms (mean difference -1.97) 3
  • Generally better tolerated than lisdexamfetamine

Topiramate (Off-Label)

  • Increases abstinence and reduces binge-eating frequency
  • Produces weight loss
  • Increases sympathetic arousal 3
  • Not specifically mentioned in APA guidelines but has research support

Treatment Sequencing Strategy

Recent research on sequential designs suggests a practical algorithm 4:

  1. Initial treatment: Start with CBT or IPT
  2. For non-responders: Switch to or add medication (lisdexamfetamine or antidepressant)
  3. For responders: Continue psychotherapy; medication maintenance may help sustain gains

Important caveat: Combining medications with psychotherapy has generally not enhanced outcomes beyond psychotherapy alone in most studies. Combined treatment appears superior to medication-only but not to psychotherapy-only 2. The exception is recent evidence showing CBT augmentation with lisdexamfetamine improves eating disorder psychopathology and weight loss, though not binge-eating outcomes specifically 4.

Lower-Intensity Options

For broader accessibility, guided self-help CBT (CBTgsh) has demonstrated efficacy and represents a scalable, lower-cost intervention 2. Web-based self-help treatment also reduces binge eating, eating disorder psychopathology, and functional impairment 4.

Essential Treatment Framework

All patients require a comprehensive, person-centered treatment plan incorporating medical, psychiatric, psychological, and nutritional expertise, ideally through a coordinated multidisciplinary team 1. This is not optional—it's a firm recommendation (1C).

Common Pitfalls to Avoid

  • Don't start with medication alone unless psychotherapy is unavailable or the patient has a strong preference—psychotherapy shows superior durability
  • Don't assume combined treatment is always better—most research shows no additive benefit of adding medication to effective psychotherapy
  • Don't overlook co-occurring conditions—depression, anxiety, and other psychiatric disorders are common and require concurrent management
  • Don't expect immediate results—assess response by 6 weeks and adjust accordingly

Special Populations

For adolescents and youth, the evidence base is much smaller. CBT shows growing evidence and is recommended by practice guidelines 5, though there are no FDA-approved medications for this age group. The adult literature suggests stimulant medication (lisdexamfetamine) has the strongest emerging position if medication is needed 5.

Weight Considerations

If weight loss is also a treatment goal, behavioral weight loss (BWL) interventions show effectiveness approximating CBT for reducing binge eating and eating disorder psychopathology, with the added benefit of modest weight loss 2. This represents an important advance for patients with concurrent obesity concerns.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.